- Investing.com
Tariff Challenges | Explore how Fortive plans to mitigate $190-220 million in tariff exposure through pricing strategies and supply chain adjustments, with a projected $0.10 EPS headwind for 2025. |
Analyst Outlook | Price targets range from $56 to $86, with an average of $77, reflecting mixed sentiment as Fortive trades at a discount to industry peers despite solid fundamentals. |
Earnings Momentum | Fortive exceeded Q3 expectations with $0.68 EPS versus $0.56 projected, prompting management to raise full-year guidance despite earlier challenges in 2025. |
Strategic Spin-off | Delve into Fortive's planned separation of Precision Technologies as Ralliant in Q2 2025, potentially unlocking shareholder value in an undervalued segment of the business. |

Metrics to compare | FTV | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipFTVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.0x | 0.0x | 11.7x | |
PEG Ratio | −1.17 | 0.00 | 0.03 | |
Price / Book | 2.8x | 0.0x | 1.4x | |
Price / LTM Sales | 3.9x | 0.0x | 1.2x | |
Upside (Analyst Target) | 14.9% | 0.0% | 28.9% | |
Fair Value Upside | Unlock | 0.0% | 7.9% | Unlock |
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.